Board of Directors

Andrew R. Midler


Mr. Midler serves as Managing Member at Savitr Capital, LLC which has its primary focus in health care venture investments. Mr. Midler founded the firm in 2008. Previously, Mr. Midler served as Chief Executive Officer and Chief Investment Officer at Standard Pacific Capital. From 1986 to 1993, he worked as a Portfolio Manager at Fidelity Investments. Mr. Midler holds an MBA from Harvard Business School. He earned MA and BA degrees in political science from Stanford University.



Patrick F. Cua


Mr. Cua has more than 30 years of healthcare leadership experience, ranging from large Fortune 500 companies to startups focused on solutions for consumers, hospitals, health plans, government entities, and Fortune 1000 employers. Mr. Cua’s industry experience began with C.R. Bard and has included executive positions with CorSolutions, Matria Healthcare, Alere, and Aetna. Mr. Cua played key roles ranging from Chairman to Senior Executive in the sale of CorSolutions to Matria , Matria to Inverness, and Pihms to Aetna. He recently helped lead the successful sale of BioIQ to the Ireland-based company, LetsGetChecked, as the Executive Chairman of the Board. Cua has built, chaired, and served on a number of boards as an NACD certified director. He currently serves as President & CEO of Glytec. In addition to his responsibilities at Glytec, he serves on the boards of various high growth healthcare technology companies.



Deborah Dean


Deborah Dean is a highly respected technology executive with more than 25 years’ experience in the healthcare industry and extensive C-level expertise in operations, technology, data integration, analytics, applications development, informatics and technical infrastructure. Most recently she served as Chief Analytics and Technology Officer at BioIQ (acquired by Let’s Get Checked), a healthcare engagement and gap closure company that is redefining the way payers, employers and consumers navigate and connect with the U.S. healthcare system. Deborah has served as Executive Vice President at MiMedx, President and Chief Operating Officer at HolaDoctor, Executive Vice President and Chief Technology officer at Matria Healthcare, and Senior Vice President of Research at Quovadx, Inc. (now Lawson software). In 2008, she received the prestigious CIO of the Year Award from the Georgia CIO Leadership Association. Deborah holds a bachelor’s degree in health services administration from Arkansas State University.



Bruce W. Bode, MD


Dr. Bode is a diabetologist and head of research at Atlanta Diabetes Associates, an NCQA-accredited physician practice and research organization specializing in the care of people with diabetes and endocrine disorders. He is also a clinical associate professor of medicine at Emory University School of Medicine. Dr. Bode is considered one of the world’s leading experts in insulin delivery and glucose sensing and is very active in clinical research on new diabetes products, including pharmacological agents, insulins, and glucose sensors. He is a member of the JDRF international research team validating the efficacy and safety of real-time continuous glucose monitoring and is a member and former president of the American Diabetes Association Georgia Chapter. Dr. Bode has written more than 200 articles, abstracts, books and book chapters in the field of diabetes and served as editor of the American Medical Association’s 2004 edition of Medical Management of Type 1 Diabetes. He also serves on the advisory boards of many leading companies in the field of diabetes care and research. Dr. Bode received a doctorate degree from Emory University School of Medicine, completed an internship and residency at Emory University Affiliated Hospitals and a fellowship in diabetes with Dr. Paul C. Davidson.